Brooks Laboratories Ltd

Brooks Lab. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Brooks Laboratories Ltd

₹ 76.8 4.48%
24 Jun - close price
brookslabs.net BSE: 533543 NSE: BROOKS
About

Incorporated in 2002, Brooks Laboratories Ltd is a pharmaceutical company working on contract basis catering to the critical care segment[1]

Key Points

Business Overview:[1]
BLL is an EU GMP & ISO 9001:2008 certified manufacturer and marketer of pharmaceutical formulations

Website BSE NSE - BE
  • Market Cap ₹ 226 Cr.
  • Current Price ₹ 76.8
  • High / Low ₹ 166 / 36.3
  • Stock P/E 38.9
  • Book Value ₹ 41.0
  • Dividend Yield 0.00 %
  • ROCE 5.27 %
  • ROE 4.93 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company has delivered good profit growth of 18.9% CAGR over last 5 years

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Tax rate seems low
  • Company has a low return on equity of 3.79% over last 3 years.
  • Contingent liabilities of Rs.75.7 Cr.
  • Promoter holding has decreased over last 3 years: -13.8%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
12.61 15.70 24.32 21.75 17.72 17.93 20.79 20.52 23.32 25.51 23.45 16.57 20.21
12.74 15.67 22.60 20.66 17.34 17.65 19.28 18.95 21.74 22.39 20.93 15.84 19.53
Operating Profit -0.13 0.03 1.72 1.09 0.38 0.28 1.51 1.57 1.58 3.12 2.52 0.73 0.68
OPM % -1.03% 0.19% 7.07% 5.01% 2.14% 1.56% 7.26% 7.65% 6.78% 12.23% 10.75% 4.41% 3.36%
0.03 0.05 0.09 0.16 0.65 0.07 0.20 0.03 0.62 0.22 0.39 0.13 0.44
Interest 0.18 0.17 0.19 0.21 0.27 0.16 0.32 0.28 0.26 0.30 0.28 0.16 0.09
Depreciation 0.44 0.44 0.44 0.43 0.46 0.40 0.43 0.38 0.39 0.39 0.39 0.39 0.41
Profit before tax -0.72 -0.53 1.18 0.61 0.30 -0.21 0.96 0.94 1.55 2.65 2.24 0.31 0.62
Tax % 0.00% 0.00% 0.00% 4.92% 0.00% 0.00% 0.00% 0.00% 11.61% 0.00% 0.00% 0.00% 0.00%
-0.71 -0.53 1.18 0.58 0.30 -0.21 0.96 0.94 1.37 2.65 2.24 0.30 0.61
EPS in Rs -0.27 -0.20 0.45 0.22 0.11 -0.08 0.37 0.36 0.47 0.90 0.76 0.10 0.21
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
85.21 80.01 57.54 55.71 55.03 69.69 76.66 76.97 55.54 79.49 82.56 85.74
78.36 68.93 52.50 64.64 63.40 72.27 75.65 75.10 61.36 76.24 77.58 78.68
Operating Profit 6.85 11.08 5.04 -8.93 -8.37 -2.58 1.01 1.87 -5.82 3.25 4.98 7.06
OPM % 8.04% 13.85% 8.76% -16.03% -15.21% -3.70% 1.32% 2.43% -10.48% 4.09% 6.03% 8.23%
5.04 1.69 0.12 0.24 2.88 -0.94 0.90 0.95 0.12 0.92 0.88 1.17
Interest 0.44 0.79 1.01 2.40 2.96 3.35 3.25 0.67 0.77 0.84 1.03 0.84
Depreciation 1.10 1.16 1.67 6.45 6.50 6.65 7.09 1.49 1.72 1.77 1.60 1.59
Profit before tax 10.35 10.82 2.48 -17.54 -14.95 -13.52 -8.43 0.66 -8.19 1.56 3.23 5.80
Tax % 8.50% 1.66% 33.06% -21.21% -0.94% 80.33% 84.82% 0.00% 0.00% 1.92% 5.57% 0.00%
9.47 10.63 1.67 -13.81 -14.81 -24.38 -15.59 0.67 -8.18 1.53 3.05 5.81
EPS in Rs 3.80 4.27 0.67 -5.55 -5.95 -9.31 -5.95 0.26 -3.12 0.58 1.04 1.97
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: 1%
5 Years: 2%
3 Years: 16%
TTM: 4%
Compounded Profit Growth
10 Years: -6%
5 Years: 19%
3 Years: 39%
TTM: 92%
Stock Price CAGR
10 Years: 1%
5 Years: -3%
3 Years: 1%
1 Year: -48%
Return on Equity
10 Years: -7%
5 Years: 1%
3 Years: 4%
Last Year: 5%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 16.19 16.19 16.19 16.19 16.19 24.70 24.70 24.70 24.70 26.25 29.46 29.46
Reserves 95.23 105.86 112.09 98.29 88.96 73.71 39.51 40.30 32.08 43.28 85.61 91.39
0.51 5.71 13.72 27.98 31.18 27.64 8.40 5.97 6.51 5.64 7.58 8.52
23.61 24.77 22.13 30.21 31.55 31.81 20.39 32.48 29.13 19.22 18.01 16.99
Total Liabilities 135.54 152.53 164.13 172.67 167.88 157.86 93.00 103.45 92.42 94.39 140.66 146.36
15.68 16.34 125.95 124.64 117.70 113.02 14.96 15.14 15.01 13.67 13.98 14.52
CWIP 52.86 86.86 0.00 0.52 0.29 0.11 0.02 1.12 0.00 0.00 0.00 1.19
Investments 0.02 0.02 0.02 0.02 0.02 0.02 46.81 46.84 46.85 46.86 90.52 90.53
66.98 49.31 38.16 47.49 49.87 44.71 31.21 40.35 30.56 33.86 36.16 40.12
Total Assets 135.54 152.53 164.13 172.67 167.88 157.86 93.00 103.45 92.42 94.39 140.66 146.36

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
2.13 8.12 9.56 -6.18 -5.05 -9.39 -0.90 3.12 0.55 -9.80 2.63 9.29
-1.12 -13.56 -16.80 -5.14 1.12 -2.33 -0.74 1.12 -0.40 0.18 -45.14 -2.92
-0.07 4.32 7.01 11.82 5.78 9.61 1.31 -4.23 -0.21 9.72 42.43 0.17
Net Cash Flow 0.94 -1.12 -0.23 0.51 1.85 -2.10 -0.33 0.02 -0.06 0.10 -0.08 6.54
Free Cash Flow -9.13 -27.78 -7.51 -11.83 -4.39 -11.54 -2.07 4.26 0.08 -10.24 1.72 6.06
CFO/OP 55% 122% 224% 60% 54% 364% 327% 181% -13% -308% 43% 131%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 82.63 86.27 67.81 66.70 75.75 81.50 45.66 71.27 83.79 74.94 88.38 68.58
Inventory Days 45.32 46.12 75.53 103.93 93.03 107.30 91.81 119.53 99.41 60.49 60.56 78.84
Days Payable 114.65 108.29 180.19 242.76 251.23 203.15 99.30 185.53 205.59 97.25 89.65 81.84
Cash Conversion Cycle 13.30 24.09 -36.85 -72.12 -82.45 -14.35 38.17 5.28 -22.39 38.18 59.28 65.58
Working Capital Days 41.64 -0.96 -26.83 -76.92 -125.82 -49.28 -5.86 2.37 -42.65 33.57 43.28 34.31
ROCE % 7.24% 9.58% 2.59% -10.64% -8.72% -6.72% -5.15% 1.49% -11.07% 3.45% 4.29% 5.27%

Insights

In beta
Mar 2013 Mar 2014 Mar 2015 Mar 2018 Feb 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Total Permanent Employees
Number

Log in to view insights

Please log in to see hidden values.

Login
Baddi Plant Capacity Utilization
%
Sales Workforce Personnel
Number
Market Authorizations Held
Number
Number of Products/Brands
Number
Installed Capacity (Vadodara Plant) - Carbapenems Injections
Million vials per annum

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

1 Recently
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
66.41% 63.59% 63.59% 63.59% 63.59% 63.59% 59.06% 52.62% 52.62% 52.62% 52.62% 52.62%
0.00% 0.00% 0.00% 0.00% 0.00% 0.02% 0.01% 0.05% 0.00% 0.01% 0.09% 0.17%
0.00% 2.46% 3.86% 3.86% 3.86% 3.86% 3.86% 10.38% 10.38% 10.38% 10.38% 10.38%
33.58% 33.94% 32.56% 32.55% 32.55% 32.53% 37.08% 36.95% 37.00% 37.00% 36.91% 36.84%
No. of Shareholders 11,21610,68610,02811,43211,54311,28210,52110,53710,31710,07810,53210,741

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Right Issue

Credit ratings